CG Oncology, Inc. Common stock (CGON)
Healthcare
Biotechnology
71.20 $
-2.5%
vs. previous close
Closing price · As of: 31. Jul 2026
CG Oncology, Inc. Common stock (CGON) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -132 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| -14 | -30 | -46 | -79 | -132 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 1.4 | |
| 1.1 | 0.7 | 1.5 | 11 | 27 | |
| -2.0 | 4.4 | 3.4 | 2.9 | 2.3 | |
| 0.1 | 0.0 | 0.0 | 0.2 | 0.1 | |
| -0.1 | -55 | -121 | -301 | -246 | |
| 15 | 0.0 | -16 | -0.4 | 0.0 | |
| 15 | 120 | 87 | 628 | 154 | |
| 1.7 | 35 | -80 | 249 | -225 | |
| -14 | -30 | -46 | -79 | -132 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.